# Dose Escalation Trial of Neoadjuvant Radiosurgery for the Treatment of Metastatic Brain Tumors

> **NCT03163368** · EARLY_PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Cedars-Sinai Medical Center** · enrollment: 25 (actual)

## Conditions studied

- Brain Metastases

## Interventions

- **RADIATION:** Neoadjuvant stereotactic radiosurgery
- **PROCEDURE:** Neurosurgical resection

## Key facts

- **NCT ID:** NCT03163368
- **Lead sponsor:** Cedars-Sinai Medical Center
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2017-05-09
- **Primary completion:** 2022-12-15
- **Final completion:** 2026-06-01
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2026-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03163368

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03163368, "Dose Escalation Trial of Neoadjuvant Radiosurgery for the Treatment of Metastatic Brain Tumors". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03163368. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*